| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.919392 |
| 003 | CaOODSP |
| 005 | 20230314133419 |
| 006 | m o d f |
| 007 | cr mn||||||||| |
| 008 | 230124e202302##oncd ob f000 0 eng d |
| 020 | |a9780660472294|q(report) |
| 020 | |a9780660472300|q(summary) |
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
| 043 | |an-cn--- |
| 086 | 1 |aHP5-153/1-2023E-PDF |
| 086 | 1 |aHP5-153/2-2023E-PDF |
| 245 | 00|aPublic health level recommendations on the use of pneumococcal vaccines in adults, including the use of 15-valent and 20-valent conjugate vaccines. |
| 264 | 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cFebruary 2023. |
| 264 | 4|c©2023 |
| 300 | |a1 online resource (102 pages) : |bcolour charts + |esummary (5 pages) |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 500 | |aIssued also in French under title: Recommandations au niveau de la santé publique sur l'utilisation des vaccins contre le pneumocoque chez les adultes, y compris l'utilisation des vaccins conjugués 15-valent et 20-valent. |
| 504 | |aIncludes bibliographical references. |
| 650 | 0|aPneumococcal vaccine|zCanada. |
| 650 | 0|aStreptococcus pneumoniae|xVaccination|zCanada. |
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
| 710 | 1 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body. |
| 775 | 08|tRecommandations au niveau de la santé publique sur l'utilisation des vaccins contre le pneumocoque chez les adultes, y compris l'utilisation des vaccins conjugués 15-valent et 20-valent.|w(CaOODSP)9.919395 |
| 856 | 40|qPDF|s2.81 MB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP5-153-1-2023-eng.pdf|z(report) |
| 856 | 40|qPDF|s262 KB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/HP5-153-2-2023-eng.pdf|z(summary) |
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/public-health-level-recommendations-use-pneumococcal-vaccines-adults-including-use-15-valent-20-valent-conjugate-vaccines.html|z(report) |
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/public-health-level-recommendations-use-pneumococcal-vaccines-adults-including-use-15-valent-20-valent-conjugate-vaccines/summary-february-2023.html|z(summary) |